Building the next generation of ADCs

Using our lightning-fast building block protein technologies and high-throughput phenotypic screening, we make and test next-generation cancer treatments at scale

Get in Touch
A downwards-pointing arrow

Our Solution

5D Combinatorial Drug Discovery: LiliumX™ Platform

a right-pointing arrow
Learn More About Our Technology

Faster Design

Rapid drug design using building blocks. Our modular Universal Assembly Platform™ can rapidly and iteratively build libraries of drug candidates from existing components, such as antibody fragments and small molecules.

Powerful Candidates

Due to our “building block” design, we can bring together multiple pieces at once to generate more powerful drug candidates across multiple fields of next-generation antibody engineering, creating unique synergies.

Better Cures

We focus on treating solid tumours with bispecific antibody-drug conjugates. Aiming at two cellular markers at once to differentiate malignant from healthy tissue – this enables us to deliver drugs more specifically and more effectively.

Noteworthy

Noteworthy

Latest News

a right-pointing arrow
See More

Backed By:

Contact Us

Say Hello

Imperial Translation & Innovation Hub
84 Wood Lane
London
W12 0BZ
England 

a tick

Message sent successfully.

a cross

Oops, something happened. Please try again.

Imperial Translation & Innovation Hub
84 Wood Lane
London
W12 0BZ
England